课题基金 / 基金详情

COVID-19 Variant Network - Analysis of Antibody Neutralization Efficiency and Cellular Immunity in SARS-CoV-2-Positive Individuals Identified in At-Risk Individuals

COVID-19 Variant Network - Analysis of Antibody Neutralization Efficiency and Cellular Immunity in SARS-CoV-2-Positive Individuals Identified in At-Risk Individuals
COVID-19 变异网络 - 在高危个体中识别出的 SARS-CoV-2 阳性个体的抗体中和效率和细胞免疫分析
批准号:
443333
负责人:
Langlois Marc-Andre
金额:
$7.29万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2021
资助国家:
加拿大
项目状态:
已结题
起止时间:
2021-02-01 至 2022-02-01

项目摘要

项目成果

Langlois Marc-Andre的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
As the COVID-19 pandemic continues its deadly course around the globe, research efforts are closely focused on viral immunity, antibody responses, and vaccine development. Increasing data from multiple reputable international medical sources now indicate
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
COVID-19 Variant Supplement - Analysis of Antibody Neutralization Efficiency and Cellular Immunity in SARS-CoV-2-Positive Individuals Identified in At-Risk Individuals
  • 批准号:
    443191
  • 项目类别:
    Operating Grants
  • 资助金额:
    $3.64万
  • 财政年份:
    2021
  • 负责人:
    Langlois Marc-Andre
  • 依托单位:
Coronavirus Variants Rapid Response Network: CoVaRR-Net - Extension
  • 批准号:
    459163
  • 项目类别:
    Directed Grant
  • 资助金额:
    $655.65万
  • 财政年份:
    2021
  • 负责人:
    Langlois Marc-Andre
  • 依托单位:
Coronavirus Variants Rapid Response Network: CoVaRR-Net
  • 批准号:
    446122
  • 项目类别:
    Operating Grants
  • 资助金额:
    $655.65万
  • 财政年份:
    2021
  • 负责人:
    Langlois Marc-Andre
  • 依托单位:
Analysis of Antibody Neutralization Efficiency and Cellular Immunity in SARS-CoV-2-Positive Individuals Identified in At-Risk Individuals
  • 批准号:
    429223
  • 项目类别:
    Operating Grants
  • 资助金额:
    $153.9万
  • 财政年份:
    2020
  • 负责人:
    Langlois Marc-Andre
  • 依托单位:
海外基金